Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44^th Annual J.P. Morgan Healthcare Conference.

A webcast of the presentation will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M^® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information. 

Contacts: 

Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Yvonne Sprow
240-720-7804
media@novavax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-302654454.html

SOURCE Novavax, Inc.